{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:24:31Z","timestamp":1780471471731,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05385-4","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T10:02:36Z","timestamp":1689069756000},"page":"2577-2582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk factors for developing calcinosis in juvenile dermatomyositis: subcutaneous and myofascial edema in initial magnetic resonance imaging"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2385-2591","authenticated-orcid":false,"given":"Belina Y.","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0600-5164","authenticated-orcid":false,"given":"Joshua","family":"Marrs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4777-0542","authenticated-orcid":false,"given":"Patricia","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4332-078X","authenticated-orcid":false,"given":"Amit","family":"Sura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6581-7618","authenticated-orcid":false,"given":"Michal","family":"Cidon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"5385_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J of Med 292:344\u2013347","journal-title":"N Engl J of Med"},{"issue":"12","key":"5385_CR2","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M et al (2017) 2017 European league against rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"5385_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11926-014-0467-y","volume":"16","author":"MF Hoeltzel","year":"2014","unstructured":"Hoeltzel MF, Oberle EJ, Robinson AB, Agarwal A, Rider LG (2014) The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis. Curr Rheumatol Rep 16(12):467. https:\/\/doi.org\/10.1007\/s11926-014-0467-y","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"5385_CR4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.semarthrit.2005.01.016","volume":"34","author":"N Boulman","year":"2005","unstructured":"Boulman N, Slobodin G, Rozenbaum M, Rosner I (2005) Calcinosis in rheumatic diseases. Semin Arthritis Rheum 34(6):805\u2013812. https:\/\/doi.org\/10.1016\/j.semarthrit.2005.01.016","journal-title":"Semin Arthritis Rheum"},{"key":"5385_CR5","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.3389\/fimmu.2018.02951","volume":"9","author":"J Wienke","year":"2018","unstructured":"Wienke J, Deakin CT, Wedderburn LR, van Wijk F, van Royen-Kerkhof A (2018) Systemic and tissue inflammation in juvenile dermatomyositis: from pathogenesis to the quest for monitoring tools. Front Immunol 9:2951. https:\/\/doi.org\/10.3389\/fimmu.2018.02951","journal-title":"Front Immunol"},{"issue":"6","key":"5385_CR6","doi-asserted-by":"publisher","first-page":"102533","DOI":"10.1016\/j.autrev.2020.102533","volume":"19","author":"MP Chung","year":"2020","unstructured":"Chung MP, Richardson C, Kirakossian D et al (2020) Calcinosis biomarkers in adult and juvenile dermatomyositis. Autoimmune Rev 19(6):102533. https:\/\/doi.org\/10.1016\/j.autrev.2020.102533","journal-title":"Autoimmune Rev"},{"issue":"1","key":"5385_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12969-018-0299-9","volume":"16","author":"AB Orandi","year":"2018","unstructured":"Orandi AB, Dharnidharka VR, Al-Hammadi N, Baszis KW (2018) CARRA legacy registry investigators. Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis. Pediatr Rheumatol Online J 16(1):84. https:\/\/doi.org\/10.1186\/s12969-018-0299-9","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"5385_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1067\/mjd.2002.12219","volume":"47","author":"RE Fisler","year":"2002","unstructured":"Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP (2002) Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 47(4):505\u2013511. https:\/\/doi.org\/10.1067\/mjd.2002.12219","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"5385_CR9","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1093\/rheumatology\/keu259","volume":"53","author":"SL Tansley","year":"2014","unstructured":"Tansley SL, Betteridge ZE, Shaddick G et al (2014) Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Rheumatology (Oxford) 53(12):2204\u20132208. https:\/\/doi.org\/10.1093\/rheumatology\/keu259","journal-title":"Rheumatology (Oxford)"},{"key":"5385_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jpeds.2017.01.046","volume":"184","author":"K Phillippi","year":"2017","unstructured":"Phillippi K, Hoeltzel M, Byun Robinson A, Kim S (2017) Childhood arthritis and rheumatology research alliance (CARRA) legacy registry investigators. Race, income, and disease outcomes in juvenile dermatomyositis. J Pediatr 184:38-44.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2017.01.046","journal-title":"J Pediatr"},{"issue":"2","key":"5385_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jpeds.2005.10.032","volume":"148","author":"LM Pachman","year":"2006","unstructured":"Pachman LM, Abbott K, Sinacore JM et al (2006) Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatr 148(2):247\u2013253. https:\/\/doi.org\/10.1016\/j.jpeds.2005.10.032","journal-title":"J Pediatr"},{"issue":"5","key":"5385_CR12","first-page":"782","volume":"28","author":"PR Mathiesen","year":"2010","unstructured":"Mathiesen PR, Zak M, Herlin T, Nielsen SM (2010) Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients. Clin Exp Rheumatol 28(5):782\u2013789","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"5385_CR13","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/rheumatology\/ker262","volume":"50","author":"WR Davis","year":"2011","unstructured":"Davis WR, Halls JE, Offiah AC, Pilkington C, Owens CM, Rosendahl K (2011) Assessment of active inflammation in juvenile dermatomyositis: a novel magnetic resonance imaging-based scoring system. Rheumatology (Oxford) 50(12):2237\u20132244. https:\/\/doi.org\/10.1093\/rheumatology\/ker262","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"5385_CR14","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1093\/rheumatology\/key144","volume":"57","author":"M Thyoka","year":"2018","unstructured":"Thyoka M, Adekunle O, Pilkington C et al (2018) Introduction of a novel magnetic resonance imaging-based scoring system for assessing disease activity in children with juvenile dermatomyositis. Rheumatology (Oxford) 57(9):1661\u20131668. https:\/\/doi.org\/10.1093\/rheumatology\/key144","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"5385_CR15","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/1529-0131(200008)43:8<1866::AID-ANR24>3.0.CO;2-6","volume":"43","author":"AB Kimball","year":"2000","unstructured":"Kimball AB, Summers RM, Turner M et al (2000) Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis Implications for diagnosis and therapy. Arthritis Rheum 43(8):1866\u20131873. https:\/\/doi.org\/10.1002\/1529-0131(200008)43:8%3c1866::AID-ANR24%3e3.0.CO;2-6","journal-title":"Arthritis Rheum"},{"key":"5385_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1546-0096-12-2","volume":"12","author":"G Faller","year":"2014","unstructured":"Faller G, Mistry BJ, Tikly M (2014) Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study. Pediatr Rheumatol Online J 12:2. https:\/\/doi.org\/10.1186\/1546-0096-12-2","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"5385_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s1090-3798(98)80021-4","volume":"2","author":"B Tabarki","year":"1998","unstructured":"Tabarki B, Ponsot G, Prieur AM, Tardieu M (1998) Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids. Eur J Paediatr Neurol 2(4):205\u2013211. https:\/\/doi.org\/10.1016\/s1090-3798(98)80021-4","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"5385_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","volume":"92","author":"LG Rider","year":"2013","unstructured":"Rider LG, Shah M, Mamyrova G et al (2013) The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 92(4):223\u2013243. https:\/\/doi.org\/10.1097\/MD.0b013e31829d08f9","journal-title":"Medicine (Baltimore)"},{"key":"5385_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2017.06.007","volume":"84","author":"SL Tansley","year":"2017","unstructured":"Tansley SL, Simou S, Shaddick G et al (2017) Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort. J Autoimmun 84:55\u201364. https:\/\/doi.org\/10.1016\/j.jaut.2017.06.007","journal-title":"J Autoimmun"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05385-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05385-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05385-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:24:47Z","timestamp":1727299487000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05385-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":19,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["5385"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05385-4","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,11]]},"assertion":[{"value":"14 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study involving human participants was deemed exempt by the Children\u2019s Hospital Los Angeles Institutional Review Board on 03\/18\/2021 given the retrospective nature of the study and use of deidentified data. The protocol number: CHLA-21-00013.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}